Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Rüssmann H[au]:

In reply. Otto-Knapp R et al. Int J Tuberc Lung Dis. (2017)

Bedaquiline as a potential agent in the treatment of <i>Mycobacterium abscessus</i> infections. Vesenbeckh S et al. Eur Respir J. (2017)

Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Barthel M et al. Infect Immun. (2003)

Search results

Items: 1 to 50 of 121

1.

[Adequate Perioperative Use of Antibiotics in Thoracic Surgery].

Engelhardt MJ, Bornemann S, Pfannschmidt J, Rüssmann H, Schönfeld N, Tiedt N, Tönnies M, Bauer TT.

Zentralbl Chir. 2019 Jul 3. doi: 10.1055/a-0915-2618. [Epub ahead of print] German.

PMID:
31269514
2.

Emergence of Low-level Delamanid and Bedaquiline Resistance During Extremely Drug-resistant Tuberculosis Treatment.

Polsfuss S, Hofmann-Thiel S, Merker M, Krieger D, Niemann S, Rüssmann H, Schönfeld N, Hoffmann H, Kranzer K.

Clin Infect Dis. 2019 Feb 2. pii: ciz074. doi: 10.1093/cid/ciz074. [Epub ahead of print]

PMID:
30933266
3.

[Effective management of an outbreak with multiresistent Klebsiella pneumoniae in a neurorehabilitation unit].

Dohle C, Korr G, Friedrichs M, Kullmann V, Tung ML, Kaase M, Rüssmann H, Sissolak D, Werber D, Becker L, Fuchs S, Pfeifer Y, Semmler T, Widders G, Eckmanns T, Werner G, Zill E, Haller S.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 May;61(5):543-552. doi: 10.1007/s00103-018-2728-9. Review. German.

PMID:
29633038
4.

Whole Genome Sequence Analysis of CTX-M-15 Producing Klebsiella Isolates Allowed Dissecting a Polyclonal Outbreak Scenario.

Becker L, Fuchs S, Pfeifer Y, Semmler T, Eckmanns T, Korr G, Sissolak D, Friedrichs M, Zill E, Tung ML, Dohle C, Kaase M, Gatermann S, Rüssmann H, Steglich M, Haller S, Werner G.

Front Microbiol. 2018 Feb 23;9:322. doi: 10.3389/fmicb.2018.00322. eCollection 2018.

5.

Bedaquiline as a potential agent in the treatment of Mycobacterium abscessus infections.

Vesenbeckh S, Schönfeld N, Roth A, Bettermann G, Krieger D, Bauer TT, Rüssmann H, Mauch H.

Eur Respir J. 2017 May 21;49(5). pii: 1700083. doi: 10.1183/13993003.00083-2017. Print 2017 May. No abstract available.

6.

Bedaquiline as a potential agent in the treatment of M. intracellulare and M. avium infections.

Vesenbeckh S, Schönfeld N, Krieger D, Bettermann G, Bauer TT, Rüssmann H, Mauch H.

Eur Respir J. 2017 Mar 22;49(3). pii: 1601969. doi: 10.1183/13993003.01969-2016. Print 2017 Mar. No abstract available.

7.

In reply.

Otto-Knapp R, Vesenbeckh S, Schönfeld N, Bettermann G, Roth A, Bauer T, Rüssmann H, Mauch H.

Int J Tuberc Lung Dis. 2017 Jan 1;21(1):123. doi: 10.5588/ijtld.16.0689-2. No abstract available.

PMID:
28157479
8.

Is delamanid a potential agent in the treatment of diseases caused by Mycobacterium avium-intracellulare?

Krieger D, Schönfeld N, Vesenbeckh S, Bettermann G, Bauer TT, Rüssmann H, Mauch H.

Eur Respir J. 2016 Dec;48(6):1803-1804. doi: 10.1183/13993003.01420-2016. Epub 2016 Nov 11. No abstract available.

9.

Benzodiazepine Use During Hospitalization: Automated Identification of Potential Medication Errors and Systematic Assessment of Preventable Adverse Events.

Niedrig DF, Hoppe L, Mächler S, Russmann H, Russmann S.

PLoS One. 2016 Oct 6;11(10):e0163224. doi: 10.1371/journal.pone.0163224. eCollection 2016.

10.

Isoniazid minimal inhibitory concentrations of tuberculosis strains with katG mutation.

Otto-Knapp R, Vesenbeckh S, Schönfeld N, Bettermann G, Roth A, Bauer T, Rüssmann H, Mauch H.

Int J Tuberc Lung Dis. 2016 Sep;20(9):1275-6. doi: 10.5588/ijtld.16.0148. No abstract available.

PMID:
27510258
11.

Neuroleptic drugs in the treatment of tuberculosis: Minimal inhibitory concentrations of different phenothiazines against Mycobacterium tuberculosis.

Vesenbeckh S, Krieger D, Bettermann G, Schönfeld N, Bauer TT, Rüssmann H, Mauch H.

Tuberculosis (Edinb). 2016 May;98:27-9. doi: 10.1016/j.tube.2016.02.003. Epub 2016 Feb 26.

PMID:
27156615
12.

Characterization of Ricin and R. communis Agglutinin Reference Materials.

Worbs S, Skiba M, Söderström M, Rapinoja ML, Zeleny R, Russmann H, Schimmel H, Vanninen P, Fredriksson SÅ, Dorner BG.

Toxins (Basel). 2015 Nov 26;7(12):4906-34. doi: 10.3390/toxins7124856.

13.

Mefloquine as a potential drug against multidrug-resistant tuberculosis.

Krieger D, Vesenbeckh S, Schönfeld N, Bettermann G, Bauer TT, Rüssmann H, Mauch H.

Eur Respir J. 2015 Nov;46(5):1503-5. doi: 10.1183/13993003.00321-2015. Epub 2015 Jul 23. No abstract available.

14.

Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.

Weiss T, Schönfeld N, Otto-Knapp R, Bös L, Bettermann G, Mauch H, Bauer TT, Rüssmann H.

Eur Respir J. 2015 Jan;45(1):285-7. doi: 10.1183/09031936.00084614. No abstract available.

15.

[Pathogenicity of Mycobacterium kansasii].

Vesenbeckh S, Wagner S, Mauch H, Roth A, Streubel A, Rüssmann H, Bauer TT, Matthiessen W, Schönfeld N.

Pneumologie. 2014 Aug;68(8):526-31. doi: 10.1055/s-0034-1377288. Epub 2014 Jul 21. German.

16.

[Resistance to second-line drugs in migrants with multidrug-resistant tuberculosis in the Berlin region].

Otto-Knapp R, Bös L, Schönfeld N, Wagner S, Starzacher AK, Weiss T, Vesenbeckh S, Glaser-Paschke G, Mauch H, Rüssmann H, Bauer TT.

Pneumologie. 2014 Jul;68(7):496-500. doi: 10.1055/s-0034-1377226. Epub 2014 Jul 9. German.

17.

[SGLT2 inhibition: an effective therapeutic approach in the treatment of diabetes mellitus?].

Rudofsky G, Rüssmann HJ, Siegmund T.

Dtsch Med Wochenschr. 2013 May;138(22):1172-7. doi: 10.1055/s-0032-1333023. Epub 2013 May 8. Review. German.

PMID:
23657992
18.

["DIabetes Versorgungs-Evaluation" (DIVE)--a national quality assurance initiative at physicians providing care for patients with diabetes].

Danne T, Kaltheuner M, Koch A, Ernst S, Rathmann W, Rüssmann HJ, Bramlage P; DIVE Studiengruppe.

Dtsch Med Wochenschr. 2013 May;138(18):934-9. doi: 10.1055/s-0033-1343144. Epub 2013 Apr 23. German.

PMID:
23613371
19.

TLR activation excludes circulating naive CD8+ T cells from gut-associated lymphoid organs in mice.

Heidegger S, Kirchner SK, Stephan N, Bohn B, Suhartha N, Hotz C, Anz D, Sandholzer N, Stecher B, Rüssmann H, Endres S, Bourquin C.

J Immunol. 2013 May 15;190(10):5313-20. doi: 10.4049/jimmunol.1202280. Epub 2013 Apr 15.

20.

Minimal inhibitory concentrations of first-line drugs of multidrug-resistant tuberculosis isolates.

Schönfeld N, Bergmann T, Vesenbeckh S, Mauch H, Bettermann G, Bauer TT, Rüssmann H.

Lung India. 2012 Oct;29(4):309-12. doi: 10.4103/0970-2113.102794.

21.

Modulation of antigenic location converts chronic into acute infection by forcing CD8+ T cell recognition.

Tzelepis F, Alcon V, Dudani R, Gurnani K, Zafer A, Everson ES, Young KG, Rüssmann H, Krishnan L, Sad S.

Cell Rep. 2012 Dec 27;2(6):1710-21. doi: 10.1016/j.celrep.2012.10.024. Epub 2012 Dec 6.

22.

In vitro susceptibility of Mycobacterium bovis against moxifloxacin.

Weiss T, Schönfeld N, Bettermann G, Blum TG, Kollmeier J, Mauch H, Bauer TT, Rüssmann H.

Int J Tuberc Lung Dis. 2012 Nov;16(11):1562. doi: 10.5588/ijtld.12.0042. No abstract available.

PMID:
23044455
23.

[Hypoglycemia: each patient's individual risk has to be evaluated].

Holstein A, Duning T, Kleophas W, Schneider A, Rüssmann HJ.

MMW Fortschr Med. 2012 May 3;154(8):62-6; quiz 67-8. German. No abstract available.

PMID:
22693761
24.

The use of interferon gamma release assays in the diagnosis of active tuberculosis.

Vesenbeckh SM, Schönfeld N, Mauch H, Bergmann T, Wagner S, Bauer TT, Rüssmann H.

Tuberc Res Treat. 2012;2012:768723. doi: 10.1155/2012/768723. Epub 2012 Jan 22.

25.

CD8 T-cell induction against vascular endothelial growth factor receptor 2 by Salmonella for vaccination purposes against a murine melanoma.

Jellbauer S, Panthel K, Hetrodt JH, Rüssmann H.

PLoS One. 2012;7(4):e34214. doi: 10.1371/journal.pone.0034214. Epub 2012 Apr 12.

26.

Value of flexible bronchoscopy in the pre-operative work-up of solitary pulmonary nodules.

Schwarz C, Schönfeld N, Bittner RC, Mairinger T, Rüssmann H, Bauer TT, Kaiser D, Loddenkemper R.

Eur Respir J. 2013 Jan;41(1):177-82. doi: 10.1183/09031936.00018612. Epub 2012 Apr 10.

27.

[Interferon-gamma release assays for hospital-based tuberculosis diagnostics in children and adolescents--a retrospective analysis].

Knappik M, Schönfeld N, Günther A, Bergmann T, Magdorf K, Rüssmann H, Mauch H, Barker M.

Pneumologie. 2012 Apr;66(4):207-11. doi: 10.1055/s-0032-1308914. Epub 2012 Apr 4. German.

28.

Plasticity of cortical inhibition in dystonia is impaired after motor learning and paired-associative stimulation.

Meunier S, Russmann H, Shamim E, Lamy JC, Hallett M.

Eur J Neurosci. 2012 Mar;35(6):975-86. doi: 10.1111/j.1460-9568.2012.08034.x.

29.

Agomelatine for Depression in Schizophrenia: A Case-Series.

Mutschler J, Rüsch N, Schönfelder H, Herwig U, Brühl AB, Grosshans M, Rössler W, Russmann H.

Psychopharmacol Bull. 2012 Feb 15;45(1):35-43.

30.

Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.

Alsleben N, Ruhwald M, Rüssmann H, Marx FM, Wahn U, Magdorf K.

Scand J Infect Dis. 2012 Apr;44(4):256-62. doi: 10.3109/00365548.2011.632644. Epub 2011 Nov 21.

PMID:
22103555
31.

Coprescription of levodopa with antipsychotics in a population of 84,596 psychiatric inpatients from 1994 to 2008.

Haueis P, Russmann S, Zorina OI, Grohmann R, Kullak-Ublick GA, Jaquenoud Sirot E, Russmann H.

Pharmacopsychiatry. 2012 Jun;45(4):127-32. doi: 10.1055/s-0031-1291348. Epub 2011 Nov 15.

32.

Mutism and amnesia following high-voltage electrical injury: psychogenic symptomatology triggered by organic dysfunction?

Mishra NK, Russmann H, Granziera C, Maeder P, Annoni JM.

Eur Neurol. 2011;66(4):229-34. doi: 10.1159/000330953. Epub 2011 Sep 27.

PMID:
21952143
33.

Successful oral desensitization to i.v. para-aminosalicylic acid (PAS) using encapsulated PAS dry substance.

Vesenbeckh SM, Becker J, Huhnt C, Karras B, Bauer TT, Mauch H, Rüssmann H, Schönfeld N.

Infection. 2012 Apr;40(2):199-202. doi: 10.1007/s15010-011-0172-y. Epub 2011 Aug 11.

PMID:
21833615
34.

Invasion and destruction of a murine fibrosarcoma by Salmonella-induced effector CD8 T cells as a therapeutic intervention against cancer.

Roider E, Jellbauer S, Köhn B, Berchtold C, Partilla M, Busch DH, Rüssmann H, Panthel K.

Cancer Immunol Immunother. 2011 Mar;60(3):371-80. doi: 10.1007/s00262-010-0950-x. Epub 2010 Dec 4.

PMID:
21132428
35.

Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.

Rüssmann H, Panthel K, Köhn B, Jellbauer S, Winter SE, Garbom S, Wolf-Watz H, Hoffmann S, Grauling-Halama S, Geginat G.

Infect Immun. 2010 Dec;78(12):5138-50. doi: 10.1128/IAI.00155-10. Epub 2010 Sep 27.

36.

A rapid change in virulence gene expression during the transition from the intestinal lumen into tissue promotes systemic dissemination of Salmonella.

Winter SE, Winter MG, Godinez I, Yang HJ, Rüssmann H, Andrews-Polymenis HL, Bäumler AJ.

PLoS Pathog. 2010 Aug 19;6(8):e1001060. doi: 10.1371/journal.ppat.1001060.

37.

Paired associative stimulation induces change in presynaptic inhibition of Ia terminals in wrist flexors in humans.

Lamy JC, Russmann H, Shamim EA, Meunier S, Hallett M.

J Neurophysiol. 2010 Aug;104(2):755-64. doi: 10.1152/jn.00761.2009. Epub 2010 Jun 10.

38.

[The unresolved problems of type 2 diabetes. Diabetology practice].

Rüssmann HJ.

Pharm Unserer Zeit. 2010 Mar;39(2):126-32. doi: 10.1002/pauz.201000360. Review. German. No abstract available.

PMID:
20196045
39.

Improved performance of a rapid office-based stool test for detection of Helicobacter pylori in children before and after therapy.

Prell C, Osterrieder S, Lottspeich C, Schwarzer A, Rüssmann H, Ossiander G, Koletzko S.

J Clin Microbiol. 2009 Dec;47(12):3980-4. doi: 10.1128/JCM.01204-09. Epub 2009 Oct 21.

40.

Superior protective immunity against murine listeriosis by combined vaccination with CpG DNA and recombinant Salmonella enterica serovar typhimurium.

Berchtold C, Panthel K, Jellbauer S, Köhn B, Roider E, Partilla M, Heesemann J, Endres S, Bourquin C, Rüssmann H.

Infect Immun. 2009 Dec;77(12):5501-8. doi: 10.1128/IAI.00700-09. Epub 2009 Sep 21.

41.

The TviA auxiliary protein renders the Salmonella enterica serotype Typhi RcsB regulon responsive to changes in osmolarity.

Winter SE, Winter MG, Thiennimitr P, Gerriets VA, Nuccio SP, Rüssmann H, Bäumler AJ.

Mol Microbiol. 2009 Oct;74(1):175-193. doi: 10.1111/j.1365-2958.2009.06859.x. Epub 2009 Aug 24.

42.

Associative plasticity in intracortical inhibitory circuits in human motor cortex.

Russmann H, Lamy JC, Shamim EA, Meunier S, Hallett M.

Clin Neurophysiol. 2009 Jun;120(6):1204-12. doi: 10.1016/j.clinph.2009.04.005. Epub 2009 May 10.

43.

Contribution of flagellin pattern recognition to intestinal inflammation during Salmonella enterica serotype typhimurium infection.

Winter SE, Thiennimitr P, Nuccio SP, Haneda T, Winter MG, Wilson RP, Russell JM, Henry T, Tran QT, Lawhon SD, Gomez G, Bevins CL, Rüssmann H, Monack DM, Adams LG, Bäumler AJ.

Infect Immun. 2009 May;77(5):1904-16. doi: 10.1128/IAI.01341-08. Epub 2009 Feb 23.

44.

Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid.

Tartz S, Rüssmann H, Kamanova J, Sebo P, Sturm A, Heussler V, Fleischer B, Jacobs T.

Vaccine. 2008 Nov 5;26(47):5935-43. doi: 10.1016/j.vaccine.2008.08.057. Epub 2008 Sep 17.

PMID:
18804138
45.

Heterologous prime-boost immunizations with different Salmonella serovars for enhanced antigen-specific CD8 T-cell induction.

Sevil Domènech VE, Panthel K, Winter SE, Rüssmann H.

Vaccine. 2008 Mar 28;26(15):1879-86. doi: 10.1016/j.vaccine.2008.01.044. Epub 2008 Feb 14.

PMID:
18313813
46.

Ambulatory monitoring of physical activities in patients with Parkinson's disease.

Salarian A, Russmann H, Vingerhoets FJ, Burkhard PR, Aminian K.

IEEE Trans Biomed Eng. 2007 Dec;54(12):2296-9.

PMID:
18075046
47.

Sub-acute delayed failure of subthalamic DBS in Parkinson's disease: the role of micro-lesion effect.

Granziera C, Pollo C, Russmann H, Staedler C, Ghika J, Villemure JG, Burkhard PR, Vingerhoets FJ.

Parkinsonism Relat Disord. 2008;14(2):109-13. Epub 2007 Dec 11.

PMID:
18065255
48.

Pre-existing anti-Salmonella vector immunity prevents the development of protective antigen-specific CD8 T-cell frequencies against murine listeriosis.

Sevil Domènech VE, Panthel K, Meinel KM, Winter SE, Rüssmann H.

Microbes Infect. 2007 Oct;9(12-13):1447-53. Epub 2007 Aug 7.

PMID:
17913544
49.

Attenuated recombinant Yersinia as live oral vaccine carrier to protect against amoebiasis.

Lotter H, Rüssmann H, Heesemann J, Tannich E.

Int J Med Microbiol. 2008 Jan;298(1-2):79-86. Epub 2007 Sep 27. Review.

PMID:
17900982
50.

Yersinia as oral live carrier vaccine: influence of Yersinia outer proteins (Yops) on the T-cell response.

Trülzsch K, Sporleder T, Leibiger R, Rüssmann H, Heesemann J.

Int J Med Microbiol. 2008 Jan;298(1-2):59-67. Epub 2007 Sep 25. Review.

PMID:
17897880

Supplemental Content

Loading ...
Support Center